The association between circulating fetuin-A levels and type 2 diabetes mellitus risk: systematic review and meta-analysis of observational studies
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The association between circulating fetuin-A levels and type 2 diabetes mellitus risk: systematic review and meta-analysis of observational studies
Authors
Keywords
Fetuin-A, Type 2 diabetes, Meta-analysis
Journal
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
Volume 41, Issue 1, Pages 33-47
Publisher
Springer Nature
Online
2017-06-22
DOI
10.1007/s40618-017-0697-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Association of plasma fetuin-a levels with peripheral arterial disease and lower extremity arterial calcification in subjects with type 2 diabetes mellitus
- (2017) Ioanna Eleftheriadou et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Fetuin-A and Risk of Diabetes Independent of Liver Fat Content
- (2016) Sarah A. Aroner et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- From infancy to aging: Biological and behavioral modifiers of Fetuin-A
- (2016) Katie N. Robinson et al. BIOCHIMIE
- Plasma fetuin-A/α2-HS-glycoprotein correlates negatively with inflammatory cytokines, chemokines and activation biomarkers in individuals with type-2 diabetes
- (2016) Sardar Sindhu et al. BMC IMMUNOLOGY
- Serum fetuin-A levels are independently correlated with vascular endothelial growth factor and C-reactive protein concentrations in type 2 diabetic patients with diabetic retinopathy
- (2016) Zhong-Wei Zhou et al. CLINICA CHIMICA ACTA
- Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus
- (2016) Alexandra Kautzky-Willer et al. ENDOCRINE REVIEWS
- Inflammatory Markers in Obese Adolescents with Type 2 Diabetes and Their Relationship to Hepatokines and Adipokines
- (2016) Thomas Reinehr et al. JOURNAL OF PEDIATRICS
- Alterations in serum levels of fetuin A and selenoprotein P in chronic hepatitis C patients with concomitant type 2 diabetes: A case-control study
- (2016) Sahar A. Ali et al. Clinics and Research in Hepatology and Gastroenterology
- Hepatokines: unlocking the multi-organ network in metabolic diseases
- (2015) Alison Iroz et al. DIABETOLOGIA
- Relationship of fibroblast growth factor 23 and fetuin-A to coronary atherosclerosis
- (2015) Fatih Akin et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Relation of Serum and Vitreous Concentrations of Fetuin-A with Diabetic Retinopathy
- (2015) Rui Jiang MEDICAL SCIENCE MONITOR
- Hepatokines as a Link between Obesity and Cardiovascular Diseases
- (2015) Hye Jin Yoo et al. Diabetes & Metabolism Journal
- Biomarkers of Vascular Calcification and Mortality in Patients with ESRD
- (2014) J. J. Scialla et al. Clinical Journal of the American Society of Nephrology
- High plasma fetuin-A levels are associated with metabolic syndrome among males but not females in a Japanese general population
- (2014) Aya Obuchi et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Serum fetuin-A concentration predicts glycaemic outcomes in people with prediabetes: a prospective study from eastern India
- (2014) D. Dutta et al. DIABETIC MEDICINE
- Fetuin-A: a novel link between obesity and related complications
- (2014) J F Trepanowski et al. INTERNATIONAL JOURNAL OF OBESITY
- Impact of the Adipokine Adiponectin and the Hepatokine Fetuin-A on the Development of Type 2 Diabetes: Prospective Cohort- and Cross-Sectional Phenotyping Studies
- (2014) Norbert Stefan et al. PLoS One
- Direct Inhibitory Effects of Pioglitazone on Hepatic Fetuin-A Expression
- (2014) Akinobu Ochi et al. PLoS One
- Salsalate and adiponectin ameliorate hepatic steatosis by inhibition of the hepatokine fetuin-A
- (2013) Tae Woo Jung et al. BIOCHEMICAL PHARMACOLOGY
- Serum fetuin-A levels are associated with the presence and severity of coronary artery disease in patients with type 2 diabetes
- (2013) Zi-Wen Zhao et al. BIOMARKERS
- Serum Levels of Fetuin-A, Osteoprotegerin and Osteopontin in Patients with Coronary Artery Disease: Effects of Statin (HMGCoA-Reductase Inhibitor) Therapy
- (2013) Nikolaos P. E. Kadoglou et al. CLINICAL DRUG INVESTIGATION
- Sex-Specific Association of Fetuin-A With Type 2 Diabetes in Older Community-Dwelling Adults: The Rancho Bernardo Study
- (2013) G. A. Laughlin et al. DIABETES CARE
- Fetuin-A is linked to improved glucose tolerance after short-term exercise training in nonalcoholic fatty liver disease
- (2013) Steven K. Malin et al. JOURNAL OF APPLIED PHYSIOLOGY
- Adipocyte Fetuin-A Contributes to Macrophage Migration into Adipose Tissue and Polarization of Macrophages
- (2013) Priyajit Chatterjee et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Comparison of Coronary Artery Calcification and Some Coronary Artery Calcification Risk Factors in Patients on Haemodialysis and in Patients with Type 2 Diabetes
- (2013) M Krajnc et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- The role of hepatokines in metabolism
- (2013) Norbert Stefan et al. Nature Reviews Endocrinology
- The Ratio of Osteoprotegerin to Fetuin-A Is Independently Associated with Vascular Stiffness in Hemodialysis Patients
- (2013) Hye Ryoun Kim et al. NEPHRON CLINICAL PRACTICE
- Association of Fetuin-A With Incident Diabetes Mellitus in Community-Living Older Adults
- (2012) Joachim H. Ix et al. CIRCULATION
- Anti-Inflammatory Role of Fetuin-A in Injury and Infection
- (2012) H. Wang et al. CURRENT MOLECULAR MEDICINE
- Plasma Levels of Fetuin-A and Hepatic Enzymes and Risk of Type 2 Diabetes in Women in the U.S.
- (2012) Qi Sun et al. DIABETES
- Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance
- (2012) Durba Pal et al. NATURE MEDICINE
- Relationship of fetuin-A levels to weight-dependent insulin resistance and type 2 diabetes mellitus
- (2012) Johannes Erdmann et al. REGULATORY PEPTIDES
- Serum fetuin-A concentrations are elevated in subjects with impaired glucose tolerance and newly diagnosed type 2 diabetes
- (2011) Horng-Yih Ou et al. CLINICAL ENDOCRINOLOGY
- Fetuin A in nonalcoholic fatty liver disease: in vivo and in vitro studies
- (2011) John Willy Haukeland et al. EUROPEAN JOURNAL OF ENDOCRINOLOGY
- Serum Fetuin-A is an Independent Marker of Insulin Resistance in Japanese Men
- (2011) Ayako Ishibashi et al. Journal of Atherosclerosis and Thrombosis
- Secretome analysis of rat adipose tissues shows location-specific roles for each depot type
- (2011) Arturo Roca-Rivada et al. Journal of Proteomics
- Serum Fetuin-A Associates with Type 2 Diabetes and Insulin Resistance in Chinese Adults
- (2011) Aiyun Song et al. PLoS One
- Gender differences in rat plasma proteome in response to high-fat diet
- (2011) Hao Liu et al. PROTEOMICS
- Serum Visfatin and Fetuin-A Levels and Glycemic Control in Patients with Obese Type 2 Diabetes Mellitus
- (2011) Fethiye Oztop Gunduz et al. Diabetes & Metabolism Journal
- NF-κB mediates lipid-induced fetuin-A expression in hepatocytes that impairs adipocyte function effecting insulin resistance
- (2010) Suman Dasgupta et al. BIOCHEMICAL JOURNAL
- Associations of Fetuin-A levels with vascular disease in type 2 diabetes patients with early diabetic nephropathy
- (2010) Marcel Roos et al. Cardiovascular Diabetology
- Poor agreement between commercial ELISAs for plasma fetuin-A: An effect of protein glycosylation?
- (2010) Edward R. Smith et al. CLINICA CHIMICA ACTA
- Fetuin-A Levels Are Increased in Patients With Type 2 Diabetes and Peripheral Arterial Disease
- (2010) D. P. Lorant et al. DIABETES CARE
- Elevated Fetuin-A Concentrations in Morbid Obesity Decrease after Dramatic Weight Loss
- (2010) Johanna Maria Brix et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Mechanisms Linking Obesity, Chronic Kidney Disease, and Fatty Liver Disease: The Roles of Fetuin-A, Adiponectin, and AMPK
- (2010) J. H. Ix et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Plasma fetuin-A concentrations in young and older high- and low-active men
- (2010) Nathan T. Jenkins et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Fetuin-A is an independent determinant of change of aortic stiffness over 1 year in non-diabetic patients with CKD stages 3 and 4
- (2010) M. L. Ford et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Adipokine Pattern in Subjects with Impaired Fasting Glucose and Impaired Glucose Tolerance in Comparison to Normal Glucose Tolerance and Diabetes
- (2010) Anke Tönjes et al. PLoS One
- Association of AHSG Gene Polymorphisms With Fetuin-A Plasma Levels and Cardiovascular Diseases in the EPIC-Potsdam Study
- (2009) Eva Fisher et al. Circulation-Cardiovascular Genetics
- Association of Lower Plasma Fetuin-A Levels With Peripheral Arterial Disease in Type 2 Diabetes
- (2009) L. H. Eraso et al. DIABETES CARE
- Diagnosis and Classification of Diabetes Mellitus
- (2009) DIABETES CARE
- Is Fetuin-A/α2-Heremans-Schmid Glycoprotein Associated with the Metabolic Syndrome in Patients with Chronic Kidney Disease?
- (2008) Jonas Axelsson et al. AMERICAN JOURNAL OF NEPHROLOGY
- Plasma Fetuin-A Levels and the Risk of Type 2 Diabetes
- (2008) N. Stefan et al. DIABETES
- Low serum fetuin-A concentration predicts poor outcome only in the presence of inflammation in prevalent haemodialysis patients
- (2008) G. Metry et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Fetuin-A and Incident Diabetes Mellitus in Older Persons
- (2008) Joachim H. Ix JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Fetuin-A Induces Cytokine Expression and Suppresses Adiponectin Production
- (2008) Anita M. Hennige et al. PLoS One
- A promoter polymorphism of the α2-HS glycoprotein gene is associated with its transcriptional activity
- (2007) Mari Inoue et al. DIABETES RESEARCH AND CLINICAL PRACTICE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started